EquityZen Growth Technology Fund LLC - Series 1760
Raised
$139K
Investors
12
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1760 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett, raising $139K from 12 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This vehicle is part of the EquityZen platform, which operates 1,889 EDGAR-registered entities focused on pre-IPO secondary market access.
This pre-IPO fund follows the standard EquityZen series structure, using combined 506(b) and 3(c)(1) exemptions with a retail-accessible $10K minimum. The $139K raise across 12 investors ($11.6K average check) is consistent with smaller series vehicles within the platform's multi-series Growth Technology Fund program.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.